Home | BioBucks

Latest Editions of BioBucks

Oct 7, 2026

Wednesday: Forbion banks €2.3B

Plus Epkinly's frontline DLBCL win and ArriVent's 57% plunge.

Oct 6, 2026

Tuesday: Vaxcyte rips, while $2B rare-disease M&A lands

Oct 5, 2026

Monday: CSL writes a $355M check for Alentis' kidney bet

Oct 2, 2026

Friday: Novartis drops $575M on Abogen's mRNA engager

Oct 1, 2026

Thursday: Sanofi hands Regeneron $1B to find the next Dupixent

Sep 30, 2026

Wednesday: uniQure's 41% gap-down and Lilly's triple-G encore

Sep 29, 2026

Tuesday: Kodiak's Eylea match and AstraZeneca's $2B Summit stake

Sep 28, 2026

Monday: AbbVie's $8.7B Cerevel bet finally ships a pill

Sep 25, 2026

Friday: ADARx prices a $446M RNAi comeback

Sep 24, 2026

Thursday: Lilly writes Beijing an up to $3.35BN check for five targets